製品名:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS番号:1273567-44-4
分子式:C11H19NO5
純度:95%
カタログ番号:CM284795
分子量:245.28

包装単位 有効在庫 価格(USD) 数量
CM284795-1g in stock ŮŮǙ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1273567-44-4
分子式:C11H19NO5
融点:-
SMILESコード:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
密度:
カタログ番号:CM284795
分子量:245.28
沸点:384.0±42.0°C at 760 mmHg
MDL番号:MFCD19442252
保管方法:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products